Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Biomarkermodel voorspelt risico op dementie bij milde cognitieve stoornissen
okt 2019 | Dementie